What if GLP-1s aren’t causing muscle loss at all? New data reveals a massive misinterpretation that could change the entire ...

High levels of lean muscle might protect against Alzheimer's disease, suggests a large study published in the open access journal BMJ Medicine. But further research is needed to tease out the ...

Movement, balance, posture, and strength “can all be altered if you have too much muscle loss,” Ravussin said. Indeed, loss ...

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss ...

Fact checked by Jennifer Klump Key Takeaways A recent study found that HIIT helped healthy older adults lose body fat and ...

Although lean body mass (including muscle) also decreases to a lesser degree, the result is still a more favorable overall body composition. Any significant weight loss (from dietary changes, ...

Lean muscle mass may offer protection against the development of Alzheimer's disease (AD), new research suggests. Investigators analyzed data on over 450,000 participants in the UK Biobank as well as ...

Share on Pinterest Research shows that Ozempic may preserve lean body mass better than Mounjaro. Image Credit: Iuliia Burmistrova/Getty Images A recent study found that semaglutide medications, such ...

Share on Pinterest New reserach suggests that msucle loss with GLP-1s may not be as high as previously thought. Bloomberg/Getty Images While past studies show that adults taking a GLP-1 medication can ...

High levels of lean muscle might protect against Alzheimer's disease, suggests a large study published in the open access journal BMJ Medicine. However, further research is needed to tease out the ...

As Miami-based Veru continues development of its enobosarm to prevent muscle wasting in patients being treated for obesity, among other conditions, the biopharma has conducted a survey showing that ...

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...